Prestige Biologics

334970 · KOSDAQ · Health Care · SMALL CAP

[Amended] Annual report (2026.06)

([Amended] Annual report (2026.06))· FILED 2026-09-28· RCEPT 20260928000204

About this filing

The annual report: audited financial statements, business overview, governance and shareholder information for the full fiscal year.

Why companies file it: Listed companies must file it within 90 days of the fiscal year end.

A full English translation of this filing is not available yet. The original (in Korean) is linked below.

Filed2026-09-28, [Amended] Annual report (2026.06)
SourceDART rcept 20260928000204 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-09-28 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).